Actually, they make a reasonable gross margin, but staff costs, promotional costs etc have been through the roof. These costs are significantly reducing. The trainwreck has happened, but that's why the shares are 10.5c.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025